SCHEMBL2097901

SCHEMBL2097901

C[SiH](C)c1c(CCCCl)ccc(O)c1C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878684 0.78 PRKCI (0.32)
SCHEMBL9074096 0.67 TYR (0.50) TYR
SCHEMBL9333540 0.65 TYR (0.51) TYR
SCHEMBL11495521 0.65 TYR (0.56) TYR
SCHEMBL816624 0.65 TYR (0.56) TYR
SCHEMBL7506307 0.64 TYR (0.46) TYR
SCHEMBL6561982 0.63 ALDH1A1 (0.37) TYR
SCHEMBL29399700 0.63 ALDH1A1 (0.37) TYR
SCHEMBL70068 0.63 ALDH1A1 (0.48) TYR
SCHEMBL30027143 0.63 ALDH1A1 (0.48) TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9115161-B2 Process for producing polycarbonates and a coordination complex used therefor SK INNOVATION CO., LTD. (KR) 2015-08-25 US disclosed
EP-2573126-B1 A PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK INNOVATION CO LTD (KR) 2014-09-24 EP disclosed
US-8829156-B2 Process for producing polycarbonates and a coordination complex used therefor SK INNOVATION CO., LTD. (KR) 2014-09-09 US disclosed
US-20140249323-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK INNOVATION CO., LTD. (KR) 2014-09-04 US disclosed
EP-2147037-B1 A PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK INNOVATION CO LTD (KR) 2014-08-20 EP disclosed
US-8530615-B2 Process for producing polycarbonates and a coordination complex used therefor SK INNOVATION CO., LTD. (KR) 2013-09-10 US disclosed
EP-2573126-A1 A process for producing polycarbonates and a coordination complex used therefor SK Innovation Co. Ltd. (KR) 2013-03-27 EP disclosed
US-20120226016-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK INNOVATION CO., LTD. (KR) 2012-09-06 US disclosed
US-20120184709-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK INNOVATION CO., LTD. (KR) 2012-07-19 US disclosed
US-8163867-B2 Process for producing polycarbonates and a coordination complex used therefor SK INNOVATION CO., LTD. (KR) 2012-04-24 US disclosed
US-20100121026-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK INNOVATION CO., LTD. (KR) 2010-05-13 US disclosed
EP-2147037-A1 A PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK Energy Co., Ltd. (KR) 2010-01-27 EP disclosed
WO-2008136591-A1 A PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR SK ENERGY CO., LTD. (KR) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184709-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR NOTUM, WEE1, WEE2 TYR 1915/4885
US-20140249323-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR NOTUM, WEE1, WEE2 TYR 1915/4885
US-20100121026-A1 PROCESS FOR PRODUCING POLYCARBONATES AND A COORDINATION COMPLEX USED THEREFOR NOTUM, WEE1, TECR TYR 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.